The chairman of the board of directors and CEO of the Merck Group in Germany, Beren Garriho, said recently that "decoupling" will lead to huge economic costs, and the investment strategy of the Merck Group in China will not change. Garriho said at a press club event in Frankfurt, Germany, on the evening of the 6th that despite geopolitical tensions, Merck Group's investment strategy in China will not change. She said that 'decoupling' will bring huge economic costs, and 'when I hear politicians say' decoupling ', I think it is not feasible... (This will) endanger a world that has already brought us prosperity, more innovation, and more cooperation.'. Merck Group, founded in 1668, focuses on innovative pharmaceutical, life science and cutting-edge functional material technology. According to its website, China is the second largest market of Merck Group in the world and the most important growth engine. (New News Agency)